您的位置: 首页 > 农业专利 > 详情页

MORPHOLINYLBENZOTRIAZINES DESTINEES A ETRE UTILISEES EN ONCOTHERAPIE
专利权人:
MERCK PATENT GMBH
发明人:
MEDERSKI, WERNER,FUCHSS, THOMAS,EMDE, ULRICH,BUCHSTALLER, HANS-PETER
申请号:
CA2856103
公开号:
CA2856103A1
申请日:
2012.10.30
申请国别(地区):
CA
年份:
2013
代理人:
摘要:
The invention relates to compounds of formula (I), where R1, L and m have the denotations as defined in the claims, and/or to the physiologically harmless salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios. The compounds of formula (I) can be used for inhibiting serine/threonine protein kinases and for sensitizing cancer cells to anticancer drugs and/or ionizing radiation. A further object of the invention is the use of the compounds of formula (I) in the prophylaxis, therapy or progress monitoring of cancers, tumors, metastases, or angiogenic disorders, in combination with radiotherapy and/or an anticancer drug. The invention further relates to a method for producing the compounds of formula (I) by reacting compounds of formulae (II) and (III) and, if need be, converting a chemical base or acid of the compounds of the formula (I) to one of the salts thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充